REFERENCES
- Jeanpierre C, Denamur E, Cabanis MO, Luce S, Cecille A, Elion J, Peuchmaur M, Loirat C, Niaudet P, Gubler MC, Junien C. Identification of constitutional WT1 mutations in patients with isolated diffuse mesangial sclerosis and analysis of genotype-phenotype correlations using a computerized database. American Journal of Human Genetics 62:824–833, 1998.
- Call KM, Glaser Y, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms tumor locus. Cell 60:509–520, 1990.
- Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GAP. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343: 774–778, 1990.
- Morrison AA, Viney RL, Landomery MR. The post-trascriptional roles of WT1, a multifunctional zinc-finger protein. Biochimica et Biophysica Acta 1785:55–62, 2008.
- Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE. Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proceedings of the National Academy of Sciences 88:9618–9622, 1991.
- Institute of Medical Genetics in Cardiff. The Human Gene Mutation database for Denys-Drash disease/phenotype accessed February 20, 2010, from http://www.hgmd.cf.ac.uk/ac/index.php.
- Coppes MJ, Campbell CE, Williams BRG. The role of WT1 in Wilms tumorigenesis. FASEB Journal 7:886–895, 1993.
- Borel F, Barilla KC, Hamilton TB, Iskandar M, Romaniuk PJ. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms tumor suppressor protein WT1. Biochemistry 35:12070–12076, 1996.
- Gilbert-Barness E, Debich-Spicer DE. Handbook of Pediatric Autopsy Pathology. Totowa, NJ: Humana Press, 2005.
- Dharnidharka VR, Ruteshouser EC, Rosen S, Kozakewich H, Harris HW -Jr, Herrin JT, Huff V. Pulmonary dysplasia, Denys-Drash syndrome and Wilms tumor 1 gene mutation in twins. Pediatric Nephrology 16:227–231, 2001.
- Kwoh C, Shannon MB, Miner JH, Shaw A. Pathogenesis of nonimmune glomerulopathies. Annual Review of Pathology: Mechanism of Diseases 1:349–374, 2006.
- Habib R. Nephrotic syndrome in the 1st year of life. Pediatric Nephrology 7(4):347–353, 1993.
- Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, Zalewski I, Imm A, Ruf EM, Mucha B, Bagga A, Neuhaus T, Fuchshuber A, Bakkaloglu A, Hildebrandt F; Arbeitsgemeinschaft Für Pädiatrische Nephrologie Study Group. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. Journal of the American Society of Nephrology 15:722–732, 2004.
- Norio R. Congenital nephrotic syndrome of Finnish type (CNF). In: Population Structure and Genetic Disorders, Eriksson A.W, Forsius HR, Nevanlinna HR, Workman PL, Norio RK, eds. New York: Academic Press, 600–604, 1980.
- Debiec H, Ronco P. Fetomaternal alloimmunization with antenatal glomerulopathies. Denys-Drash syndrome New York Academy of Sciences 1110:559–566, 2007.
- Timpl R, Brown JC. The laminins. Matrix Biology 14:275–281, 1994.
- Sibley RK, Striegel J. Nephrotic syndrome in the first year of life. In: Renal Pathology: With Clinical and Functional Correlations, Tisher CC, Brenner BH, eds. Baltimore, MD: JB Lippincott, 1291–1311, 1994.